Updates are available Correction dated 2018-12-17
Click to view Correction: https://doi.org/10.1007/s40262-018-0723-9
-
Authors
Germovsek, Eva https://orcid.org/0000-0003-2935-0090
Barker, Charlotte I. S.
Sharland, Mike
Standing, Joseph F.
-
Funding
Funding for this research was provided by:
European Union Seventh Framework Programme for Research, Technological Development and Demonstration (242146, 261060)
Action Medical Research (SP4650, GN1834)
Medical Research Council (G1002305, M008665)
National Institute for Health Research (ACF-2016-18-016)
- License Information
-
More Information
Article History
First Online: 19 April 2018
Change Date: 17 December 2018
Change Type: Correction
Change Details: The article Pharmacokinetic–Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance Written by Eva Germovsek,Charlotte I. S. Barker, Mike Sharland, Joseph F. Standing was incorrectly published electronically on the publisher’s internet portal (currently Springer Link) on [20th April, 2018] with Open access under Non-commercial License.
Compliance with Ethical Standards
:
: No specific external funding was used in the preparation of this manuscript. EG was supported by an IMPACT PhD studentship from University College London (UCL), and received funding from the NeoMero study, part of the EU Seventh Framework Programme for Research, Technological Development and Demonstration (Grant agreement number 242146), and from Action Medical Research (Grant code SP4650, GN1834). CISB was funded as a Clinical Research Fellow by the Global Research in Paediatrics Network of Excellence (GRiP), part of the EU’s Seventh Framework Programme for Research, Technological Development and Demonstration (FP7/2007–2013, Grant agreement number 261060), and is now funded by a National Institute for Health Research (NIHR) Academic Clinical Fellowship (ACF-2016-18-016). MS chairs the UK Department of Health Expert Advisory Committee on Antimicrobial Resistance and Healthcare-Associated Infection, is an independent scientific advisor to the National Institute for Health and Care Excellence (NICE), and also receives institutional academic research grants from the NIHR and the EU. JFS has received funding from UK Medical Research Council Fellowships (Grants G1002305 and M008665). ES, CISB and JFS have been supported by the NIHR Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust, and University College London.
: Eva Germovsek, Charlotte I.S. Barker, Mike Sharland, and Joseph F. Standing declare that they have no conflicts of interest that might be relevant to the contents of this manuscript.
